View in EDS HTML Full Text PDF Full Text

Cost-utility analysis of lenvatinib and sorafenib for the first-line treatment of unresectable hepatocellular carcinoma in Vietnam: Evidence from a lower-middle income country.

Saved in:
Bibliographic Details
Title: Cost-utility analysis of lenvatinib and sorafenib for the first-line treatment of unresectable hepatocellular carcinoma in Vietnam: Evidence from a lower-middle income country.
Authors: Do, Thang Xuan1 (AUTHOR), Nguyen, Ha Thi2 (AUTHOR) nthiha@uhsvnu.edu.vn, Nguyen, Phuong Thi Lan2 (AUTHOR), Kieu, Mai Thi Tuyet1 (AUTHOR), Duong, Tuan Viet1 (AUTHOR), Pham, Van Nu Hanh1 (AUTHOR)
Source: PLoS ONE. 4/3/2026, Vol. 21 Issue 4, p1-13. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 192763514
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cost-utility analysis of lenvatinib and sorafenib for the first-line treatment of unresectable hepatocellular carcinoma in Vietnam: Evidence from a lower-middle income country.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Do%2C+Thang+Xuan%22">Do, Thang Xuan</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nguyen%2C+Ha+Thi%22">Nguyen, Ha Thi</searchLink><relatesTo>2</relatesTo> (AUTHOR)<i> nthiha@uhsvnu.edu.vn</i><br /><searchLink fieldCode="AR" term="%22Nguyen%2C+Phuong+Thi+Lan%22">Nguyen, Phuong Thi Lan</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kieu%2C+Mai+Thi+Tuyet%22">Kieu, Mai Thi Tuyet</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Duong%2C+Tuan+Viet%22">Duong, Tuan Viet</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pham%2C+Van+Nu+Hanh%22">Pham, Van Nu Hanh</searchLink><relatesTo>1</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22PLoS+ONE%22">PLoS ONE</searchLink>. 4/3/2026, Vol. 21 Issue 4, p1-13. 13p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=192763514
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.pone.0345212
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 13
        StartPage: 1
    Titles:
      – TitleFull: Cost-utility analysis of lenvatinib and sorafenib for the first-line treatment of unresectable hepatocellular carcinoma in Vietnam: Evidence from a lower-middle income country.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Do, Thang Xuan
      – PersonEntity:
          Name:
            NameFull: Nguyen, Ha Thi
      – PersonEntity:
          Name:
            NameFull: Nguyen, Phuong Thi Lan
      – PersonEntity:
          Name:
            NameFull: Kieu, Mai Thi Tuyet
      – PersonEntity:
          Name:
            NameFull: Duong, Tuan Viet
      – PersonEntity:
          Name:
            NameFull: Pham, Van Nu Hanh
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 04
              Text: 4/3/2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 19326203
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: PLoS ONE
              Type: main
ResultId 1